 |
Previous Article | Next Article 
The Journal of Neuroscience, March 15, 1999, 19(6):1922-1931
The Synaptophysin-Synaptobrevin Complex: a Hallmark of Synaptic
Vesicle Maturation
Anja
Becher1,
Anne
Drenckhahn1,
Ingrid
Pahner1,
Martin
Margittai2,
Reinhard
Jahn2, and
Gudrun
Ahnert-Hilger1
1 Institut für Anatomie der Charité,
Humboldt-Universität zu Berlin, 10115 Berlin, Germany, and
2 Max Planck Institut für Biophysikalische Chemie,
37077 Göttingen, Germany
 |
ABSTRACT |
Exocytosis of synaptic vesicles requires the formation of a fusion
complex consisting of the synaptic vesicle protein synaptobrevin (vesicle-associated membrane protein, or VAMP) and the plasma membrane proteins syntaxin and soluble synaptosomal-associated protein
of 25 kDa (or SNAP 25). In search of mechanisms that regulate the
assembly of the fusion complex, it was found that synaptobrevin also
binds to the vesicle protein synaptophysin and that synaptophysin-bound synaptobrevin cannot enter the fusion complex. Using a combination of
immunoprecipitation, cross-linking, and in vitro
interaction experiments, we report here that the
synaptophysin-synaptobrevin complex is upregulated during neuronal
development. In embryonic rat brain, the complex is not detectable,
although synaptophysin and synaptobrevin are expressed and are
localized to the same nerve terminals and to the same pool of vesicles.
In contrast, the ability of synaptobrevin to participate in the fusion
complex is detectable as early as embryonic day 14. The binding of
synaptoporin, a closely related homolog of synaptophysin, to
synaptobrevin changes in a similar manner during development.
Recombinant synaptobrevin binds to synaptophysin derived from adult
brain extracts but not to that derived from embryonic brain extracts.
Furthermore, the soluble cytosol fraction of adult, but not of
embryonic, synaptosomes contains a protein that induces
synaptophysin-synaptobrevin complex formation in embryonic vesicle
fractions. We conclude that complex formation is regulated during
development and is mediated by a posttranslational modification of
synaptophysin. Furthermore, we propose that the
synaptophysin-synaptobrevin complex is not essential for exocytosis
but rather provides a reserve pool of synaptobrevin for exocytosis that
can be readily recruited during periods of high synaptic activity.
Key words:
synaptophysin-synaptobrevin complex; SNARE proteins; synaptic vesicles; fine-tuning of exocytosis; synapse maturation; neuronal development
 |
INTRODUCTION |
Exocytosis of synaptic vesicles is
mediated by a conserved set of membrane proteins that are commonly
referred to as SNAREs [soluble N-ethylmaleimide-sensitive
factor attachment protein (SNAP) receptors]. These proteins
include synaptobrevin [or vesicle-associated membrane protein
(VAMP)], which is localized in the membrane of synaptic vesicles, and
syntaxin 1 and SNAP 25, which are predominantly localized at the
synaptic plasma membrane. In vitro, these proteins spontaneously form a tight stoichiometric complex that can be disassembled by interaction with the proteins -SNAP and the ATPase N-ethylmaleimide-sensitive factor (NSF)
(Söllner et al., 1993 ). The cyclic assembly-disassemby of SNARE
proteins is one of the crucial steps in exocytotic membrane fusion. The
core of the ternary complex consists of a rod-shaped long bundle of
helices, with all membrane anchors aligned at one end (Hanson et al.,
1997a ; Sutton et al., 1999 ). Based on these studies, a picture is
emerging according to which SNARE assembly results in the tight binding of the vesicle to the plasma membrane, largely overcoming the energy
barrier for fusion (Hanson et al., 1997b ; Jahn and Hanson, 1998 ).
Much less is known about how the formation of the ternary complex
is regulated. Because assembly occurs spontaneously and is irreversible
in the absence of NSF and -SNAP, a tight control of this assembly
reaction may be instrumental for intracellular membrane traffic.
Therefore, special attention has been given recently to proteins that
selectively bind to one of the SNAREs and thus prevent it from
interacting with its SNARE partners. For syntaxin, the best candidate
for such a control protein is the protein munc-18, the mammalian
version of Caenorhabditis elegans unc-18, which is
known to be essential for exocytosis. Syntaxin that is complexed to
munc-18 appears to be unable to interact with SNAP 25 and synaptobrevin
(Hata et al., 1993 ; Okamoto and Südhof, 1997 ). Furthermore,
numerous other proteins were identified that selectively interact with
syntaxin 1, such as munc-13-1 (Betz et al., 1997 ), but in most cases
the functional significance of these interactions remains to be
established. For synaptobrevin, only one group of non-SNARE binding
partner proteins is known: the membrane protein synaptophysin and its
closely related isoform synaptoporin. Synaptophysins are major
residents of the synaptic vesicle membrane. The binding to
synaptobrevin is specific and exclusive; synaptobrevin bound to
synaptophysin cannot enter the SNARE complex and, conversely,
synaptobrevin, which is part of a SNARE complex, cannot interact with
synaptophysin (Calakos and Scheller, 1994 ; Edelmann et al., 1995 ).
These findings led to the proposal that synaptophysin serves as a
control protein that regulates the availability of synaptobrevin for
engaging with its SNARE partners before fusion. However, direct
evidence for such a regulatory role is lacking. Furthermore, the nature
and the potential regulation of the synaptophysin-synaptobrevin
interaction are still unknown.
In the present study, we have attempted to learn more about the
significance of the synaptophysin-synaptobrevin interaction for
neuronal exocytosis. Specifically, we have investigated whether this
interaction is a basic feature of all synaptobrevin-dependent membrane
fusion events or whether it exists solely in fully differentiated presynaptic terminals. During neuronal development, most components of
the exocytotic machinery are expressed long before differentiated synapses are established (Fletcher et al., 1991 ; Matteoli et al., 1995 ;
Ahnert-Hilger et al., 1996 ). Our findings show that during these early
phases, synaptophysin is unable to bind to synaptobrevin but acquires
binding capability during later developmental stages parallel to
synaptogenesis. Furthermore, we found that this change is caused
by a still unknown modification of synaptophysin that is
mediated by a synaptosomal cytosolic factor present in adult brain.
This article contains part of the PhD thesis of Anja Becher.
 |
MATERIALS AND METHODS |
Antibodies. The following antibodies were described
previously: mouse monoclonal antibodies against synaptobrevin II (clone 69.1; Edelmann et al., 1995 ); synaptophysin (clone 7.2; Jahn et al.,
1985 ); synaptotagmin (clone 41.1; Brose et al., 1992 ); and rabbit
polyclonal antisera against synaptophysin (Jahn et al., 1985 ). The
hybridoma line HPC-1 (syntaxin 1) was kindly provided by C. Barnstable
(Yale University, Hartford, CT) (Barnstable et al., 1985 ) and later
grown from our own stocks. Rabbit sera directed against the
following proteins were kind gifts: synaptobrevin (provided by T. Rapoport, Harvard Medical School, Boston, MA) (Kutay et al., 1995 );
synaptoporin (provided by T. C. Südhof, Howard Hughes
Medical Institute, University of Texas, Dallas, TX); and -subunit of
the potassium channel Kv1.6 (provided by R. Veh, Institut für
Anatomie der Charité, Humboldt-Universität Berlin, Germany)
(Veh et al., 1995 ). A monoclonal antibody against SNAP 25 was purchased
from Sternberger Monoclonals (Baltimore, MD). Secondary antibodies for
Western blot detection, horse anti-mouse, and goat anti-rabbit,
conjugated with either horseradish peroxidase or alkaline phosphatase,
were purchased from Vector Laboratories (Burlingame, CA). For
immunocytochemical detection, goat anti-mouse labeled with Cy5 (Jackson
ImmunoResearch, West Grove, PA) and goat anti-rabbit labeled with Cy2
(Amersham, Arlington Heights, IL) were used.
Synaptosomes. Isolated nerve terminals (crude synaptosomes)
were prepared at 4°C from adult and embryonic rat whole brains in the
presence of protease inhibitors (Edelmann et al., 1995 ). After
homogenization in 0.32 M sucrose (nine strokes at 900 rpm) and centrifugation at 2,500 × g for 2 min, the
supernatants were centrifuged at 13,000 × g for 12 min. Crude synaptosomes (1-2 mg of protein) were dissolved in 1 ml
extraction buffer containing (in mM): KCl 140, EDTA 2, HEPES-KOH 20, pH 7.3, and 1% (v/v) Triton X-100. Extraction was
performed for 1 hr at 4°C, followed by centrifugation for 3 min at
700 × g. Three microliters of ascites fluid
(corresponding to ~10 µg of IgG) of the monoclonal antibodies
against synaptobrevin, synaptophysin, or syntaxin were added to 200 µl of extraction supernatant. Incubation was performed for 16-18 hr.
Immunoprecipitates were separated by addition of 25 µl of G-Sepharose
suspension (Pharmacia Biotech, Piscataway, NJ). The beads were
collected by centrifugation at 200 × g for 1 min,
washed three times in extraction buffer, and analyzed by SDS-PAGE and
Western blotting. The supernatant of the immunoprecipitate was analyzed
in parallel.
For cross-linking experiments, synaptosomes were resuspended in
Krebs'-Ringer's buffer containing (in mM): NaCl 140, NaHCO3 5, MgCl2 1, Na2HPO4 1.2, glucose 10, and HEPES-NaOH 20, pH
7.4. Synaptosomes [1.5 mg/ml protein for adult, 4 mg/ml for embryonic day 20 (E20)] were prewarmed at room temperature for 10 min.
The chemical cross-linker disuccinimidyl suberate (DSS) dissolved in
dimethyl sulfoxide was added to yield a final concentration of 0.5 mM. After incubation at room temperature for 45 min, while shaking, the reaction was quenched by the addition of Tris-HCl, pH 7.4 (final concentration 100 mM) and incubated for an
additional 30 min. Membranes were subsequently pelleted at
350,000 × g for 30 min and analyzed by SDS-PAGE and
immunoblotting using nondenaturating conditions.
Synaptic vesicles and synaptosomal cytosol. Crude synaptic
vesicles [lysis pellet 2 (LP2) fraction] were prepared from adult and
embryonic brains following the procedure described by Huttner et al.
(1983) . The resulting supernatant [lysis supernatant 2 (LS2)] was
used as synaptosomal cytosol. For protein digestion, 0.2 mg/ml trypsin
was added during LS2 sample preparation and inactivated before
incubation with LP2.
Immunoisolation. Brains were homogenized in 0.32 M sucrose (2000 rpm, 10 strokes) and spun down at
35,000 × g for 25 min. Three hundred microliters of
the resulting supernatant were incubated with 1-3 µl of a
suspension of Eupergit C1Z beads (Roehm Pharma, Weiterstadt, Germany)
coupled to monoclonal antibodies against synaptobrevin, synaptophysin,
or glycine (as control) for 45 min at 4°C. Beads were centrifuged at
7,500 × g for 2 min, and the pellets were washed three
times (Walch-Solimena et al., 1995 ). Proteins in the bead pellet and
the supernatant were analyzed by SDS-PAGE and Western blotting.
Cell culture. PC 12 cells were cultivated in DMEM
supplemented with 10% horse and 5% fetal calf serum. Before use,
cells were harvested, washed in PBS, and pelleted.
Recombinant synaptobrevins. Full-length rat synaptobrevin II
(residues 1-116) was subcloned into the NdeI and
EcoRI sites of the vector pHO2c (Fasshauer et al., 1997 ).
Synaptobrevin II without the transmembrane region (residues 1-96) was
subcloned into TrcHisA (Invitrogen, San Diego, CA) as described
previously (Chapman et al., 1994 ). The His6-tagged fusion proteins were
purified by Ni2+-Sepharose chromatography and
eluted by a stepwise increase of the imidazole concentration. The
eluate was analyzed by SDS-PAGE and Coomassie blue staining.
Recombinant synaptobrevins were immobilized on Ni-beads via their His
tag and used for binding studies with synaptophysin from adult and
embryonic vesicles and from PC 12 cells. Binding was performed in PBS
containing 3-[(3-cholamiolopropyl)dimethylammonio-1-propane sulfonic
acid (1.5% w/v) or Triton X-100 (1% v/v). Incubations were performed
for 16-18 hr, after which the beads were pelleted and washed three
times. Proteins in the bead pellet, as well as the supernatant, were
analyzed by SDS-PAGE and Western blotting.
Immunocytochemistry. Freshly removed cerebella from E21 or
adult rats were placed in ice-cold PBS and cut into small cubes of ~8
mm3. These were fixed in 4% formaline in 0.1 M phosphate buffer, pH 7.4, for 1 hr on ice and 2 hr at
room temperature and subsequently immersed in 30% sucrose in PBS
overnight. The tissue was shock-frozen in tissue-freezing medium (Jung
Leica, Nussloch, Germany). Ten micrometer sections were prepared using
a cryostat and mounted on poly-D-lysine (Sigma, St. Louis,
MO)-coated slides. After three rinses with PBS, sections were incubated
with a blocking solution containing 5% normal goat serum (Pan Systems,
Nuerenberg, Germany) and 2% bovine serum albumin, pH 7.0 (fraction V;
Serva Feinbiochemica, Heidelberg, Germany) dissolved in PBS
supplemented with 0.1% Triton X-100 for 1 hr at room temperature.
Incubation with a mixture of polyclonal and monoclonal
antibodies against synaptobrevin and synaptophysin diluted in blocking
solution was performed overnight at 4°C. Immunofluorescence was
detected with Cy5-labeled goat anti-mouse and Cy2-labeled goat
anti-rabbit and analyzed by confocal laser microscopy.
 |
RESULTS |
Synaptophysin-synaptobrevin complex and SNARE complex in adult and
embryonic brains
Synaptobrevin occurs in two mutually exclusive complexes: the
SNARE complex and a complex with synaptophysin. Using
coimmunoprecipitation, we first analyzed these two complexes in
synaptosomes from embryonic brain, starting with E14, compared with
synaptosomes from adult brain. In adult synaptosomes, the monoclonal
antibody against synaptobrevin coimmunoprecipitated the two other SNARE
proteins, syntaxin and SNAP 25, as well as synaptophysin. The antibody
against syntaxin precipitated only synaptobrevin and SNAP 25, leaving synaptophysin in the supernatant, and the synaptophysin antibody clearly precipitated only synaptobrevin. The
synaptophysin-synaptobrevin complex dissociated when synaptosomes
were treated with SDS. These findings are in agreement with
previous reports (Calakos and Scheller, 1994 ; Edelmann et al.,
1995 ). However, when synaptosomes from E14 or E20 were used, the
synaptophysin-synaptobrevin complex could not be detected when
immunoprecipitated with antibodies against synaptophysin or
synaptobrevin, although synaptophysin could clearly be seen in the
supernatants after precipitation with the synaptobrevin or the syntaxin
antibody, respectively. In contrast, the antibodies specific for
syntaxin and synaptobrevin precipitated assembled SNARE complexes (Fig.
1), demonstrating that synaptobrevin is
not impaired in its ability to enter such complexes. In both cases,
synaptotagmin, an integral membrane protein colocalizing with
synaptobrevin to synaptic vesicles, was always found in the supernatant
(Fig. 1, top two panels).

View larger version (74K):
[in this window]
[in a new window]
|
Figure 1.
SNARE complex, synaptophysin, and the
synaptophysin-synaptobrevin complex in embryonic and adult
synaptosomes. Triton X-100 extracts of whole brain crude synaptosomal
fractions during different stages of development were
immunoprecipitated using monoclonal antibodies against synaptobrevin
(syb), synaptophysin (syp), or syntaxin
(syn). Immunoprecipitates (IP) and their
corresponding supernatants (S) were analyzed
using antibodies against the indicated proteins.
|
|
Varying the ratio between protein amount and Triton X-100 gave similar
results, excluding that detergent artifacts caused the lack of
synaptophysin-synaptobrevin interaction in embryonic samples (data not
shown). The synaptophysin-synaptobrevin complex could not be detected
in embryonic synaptosomes, even when the amount of protein for
immunodetection was increased approximately tenfold (data not shown).
The difference in the synaptophysin-synaptobrevin complex between
adult and embryonic brains was also observed when using polyclonal
antisera for immunodetection (data not shown).
To confirm the absence of synaptophysin-synaptobrevin complexes in
embryonic brains by an independent approach, we incubated synaptosomes
with the cross-linker DSS. This cross-linker is membrane-permeable and
allows for an analysis of the complex in intact membranes, i.e.,
without the need for detergent solubilization (Johnston and
Südhof, 1990 ; Calakos and Scheller, 1994 ; Edelmann et al., 1995 ).
When synaptosomes from adult brain were used, DSS treatment resulted in
the generation of two adducts of ~36 and 56 kDa, which represent the
synaptobrevin dimer and the synaptobrevin-synaptophysin complex,
respectively. In embryonic synaptosomes, no adduct corresponding to the
synaptophysin-synaptobrevin complex was present. Furthermore, only
small amounts of the synaptobrevin dimer were detected (Fig. 2). A similar pattern was obtained when
immunoprecipitation with both synaptobrevin- and synaptophysin
antibodies was performed before electrophoretic analysis (data not
shown).

View larger version (39K):
[in this window]
[in a new window]
|
Figure 2.
Complexes of synaptophysin and
synaptobrevin after chemical cross-linking in embryonic and adult
synaptosomes. Crude synaptosomal fractions from embryonic day
(ED) 20 whole brain (4 mg/ml protein) or adult whole
brain (1.5 mg/ml protein) were treated with disuccinimidyl suberate
(DSS) as described in Materials and Methods. After
SDS-PAGE and Western blotting, membranes were analyzed using the
monoclonal antibody against synaptobrevin. Note that cross-linking
reveals the synaptobrevin dimer and the synaptobrevin-synaptophysin
complex in the adult synaptosomes, whereas no
synaptobrevin-synaptophysin complex and only traces of the
synaptobrevin dimer can be detected in embryonic synaptosomes.
C, Control.
|
|
Next, we investigated whether the second isoform of synaptophysin,
synaptoporin, shows a comparable pattern of complex formation with
synaptobrevin. In embryonic synaptosomes, synaptoporin could also be
detected as early as E14. Like synaptophysin, synaptoporin did not form
complexes with synaptobrevin in embryonic synaptosomes, whereas, as
shown previously (Edelmann et al., 1995 ), the
synaptoporin-synaptobrevin complex was present in adult synaptosomes
(Fig. 3).

View larger version (31K):
[in this window]
[in a new window]
|
Figure 3.
Synaptoporin and the synaptoporin-synaptobrevin
complex in embryonic and adult synaptosomes. Triton X-100 extracts of
whole brain crude synaptosomal fractions during different stages of
development were immunoprecipitated using the monoclonal antibody
against synaptobrevin. Immunoprecipitates (IP) and their
corresponding supernatants (S) were analyzed
using an antiserum against the synaptophysin analog synaptoporin.
|
|
Next, we tested for the presence of the synaptophysin-synaptobrevin
complex at several early postnatal time points, starting at birth. As
shown in Figure 4, the
synaptophysin-synaptobrevin complex appeared only after birth,
starting at approximately postnatal day 2-5 and reaching adult levels
at approximately postnatal day 15.

View larger version (46K):
[in this window]
[in a new window]
|
Figure 4.
Postnatal appearance of the
synaptophysin-synaptobrevin complex. Triton X-100 extracts of whole
brain crude synaptosomal fractions from different stages of postnatal
development were immunoprecipitated using the monoclonal antibody
against synaptophysin. Immunoprecipitates (IP) and their
corresponding supernatants (S) were analyzed
using an antibody against synaptobrevin.
|
|
Failure of synaptophysin to complex synaptobrevin in embryonic
neurons is not attributable to a differential sorting
The data discussed so far shows that in embryonic brain
synaptophysin and synaptobrevin are expressed but fail to complex. An
obvious explanation for this observation may be that the two proteins
do not reside on the same vesicle population during early development.
For instance, the proteins may first be expressed preferably in
different subsets of neurons. Alternatively, the proteins may reside in
the same neurons but may localize to different membrane compartments
before the formation of mature synapses. To test for regional
differences in protein expression, we analyzed the distribution of
synaptophysin and synaptobrevin in slices from adult and embryonic
cerebella using double-label immunocytochemistry (Fig.
5A). In the cerebellar cortex
of E18 rats, both proteins showed a complete colocalization in the
molecular layer and the granular layer. This resembles the
colocalization of both proteins in adult cortex (Baumert et al., 1989 )
and excludes differential expression as the cause for the absence of
the complex. Immunoprecipitation from adult and embryonic cerebella
reflected the results obtained in whole brain (Fig. 5B).

View larger version (74K):
[in this window]
[in a new window]
|
Figure 5.
Synaptophysin, synaptobrevin, and the
synaptophysin-synaptobrevin complex in embryonic and adult cerebellum.
A, Confocal laser microscopic analysis of synaptophysin
and synaptobrevin in embryonic day 18 rat cerebellar cortex. Note the
clear presence of synaptophysin (left) and synaptobrevin
(right) in the developing molecular and granular layers
and the almost complete colocalization of both antigens.
B, Triton X-100 extracts of cerebellar crude
synaptosomal fraction from embryonic day 18 or adult were
immunoprecipitated using antibodies against synaptophysin or
synaptobrevin. Immunoprecipitates (IP) and their
corresponding supernatants (S) were
analyzed using anti-synaptophysin or anti-synaptobrevin antibody. No
synaptobrevin-synaptophysin complex could be detected in the embryonic
cerebellar synaptosomes.
|
|
Although the immunocytochemical data demonstrate that both
synaptophysin and synaptobrevin are coexpressed in the same neurons as
early as E18, it cannot be excluded that the two proteins are localized
to different and complementary vesicle subpopulations that cannot be
differentiated at the light microscopic level. To test for this
possibility, we immunoisolated synaptophysin-containing vesicles from
adult and embryonic brains using Eupergit beads coated with
synaptophysin antibodies. This procedure was shown previously to result
in the one-step isolation of membranes, with exceptional purity (Burger
et al., 1989 ; Walch-Solimena et al., 1995 ). As shown in Figure
6, vesicles isolated by this procedure contained both synaptophysin and synaptobrevin, regardless of whether
they were obtained from adult or embryonic brain. Neither synaptophysin
nor synaptobrevin was detectable on control beads devoid of antibody.
As an independent control, we also tested for the presence of the subunit of the potassium channel Kv1.6, an integral membrane protein
that is known to be localized to the plasma membrane. This protein did
not bind to the beads and was found only in the supernatants of the
immunoprecipitates (Fig. 6). These data demonstrate that synaptophysin
and synaptobrevin occur on the same vesicle in both adult and embryonic
brain and that their failure to complex is not because of a
differential localization in embryonic neurons.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 6.
Immunoisolation of synaptic vesicles from
embryonic and adult whole brain. Eupergit beads coated with either an
antibody against synaptophysin or glycine as negative control
were incubated with crude synaptic vesicle fractions as described
in Materials and Methods. Membranes adsorbed to the beads, as well as
the corresponding supernatants, were analyzed using antibodies against
synaptobrevin, synaptophysin, or the subunit of the Kv1.6 channel.
Only beads coated with the antibody against synaptophysin pelleted
synaptobrevin and synaptophysin from both embryonic and adult vesicles.
The potassium channel protein was always detected in the
supernatant.
|
|
Association is regulated by a change in synaptophysin during
development that is controlled by a cytosolic protein
The data described above indicates that the
synaptophysin-synaptobrevin interaction is directly regulated on the
surface of the synaptic vesicle and their precursor membranes. Such
regulation may be achieved by either a direct posttranslational
modification of one or both of the proteins, or an interaction between
an unknown control protein and one of the binding partners. To pinpoint
the mechanism for the developmental change, we first investigated which
of the two proteins differs in its ability to interact with its
partner. Recombinant synaptobrevin was generated by bacterial expression and incubated with detergent extracts derived from both
embryonic and adult brain. As shown in Figure
7, only synaptophysin from adult
synaptosomes bound to synaptobrevin, whereas synaptophysin from
embryonic synaptosomes did not. In contrast, SNAP 25 and syntaxin from
both preparations bound to recombinant synaptobrevin (Fig.
7A). As shown previously (Edelmann et al., 1995 ), no binding was observed when only the cytoplasmic portion of synaptobrevin was
used, whereas the binding of the SNARE partners was not affected (Fig.
7B). These data strongly suggest that the biochemical
properties of synaptobrevin remain unchanged during development and
resemble that of bacterially expressed synaptobrevin. We conclude that embryonic synaptophysin differs from adult synaptophysin.

View larger version (46K):
[in this window]
[in a new window]
|
Figure 7.
Binding of recombinant synaptobrevin
constructs to embryonic and adult synaptic vesicles. Crude synaptic
vesicle extracts from embryonic or adult brain were incubated with
either full-length synaptobrevin (1-116) or the N-terminal part of
synaptobrevin (1-96) (see Materials and Methods). The bead pellets and
the corresponding supernatants were analyzed using antibodies against
synaptophysin, SNAP 25, and syntaxin.
|
|
In the neuroendocrine cell line PC 12, the synaptophysin-synaptobrevin
complex was also absent, although both proteins were present, as shown
by immunoprecipitation with the relevant antibodies (Fig.
8A). Again, as in
embryonic neurons, PC 12 synaptophysin was unable to bind recombinant
synaptobrevin, although the SNARE proteins SNAP 25 and syntaxin were
clearly able to interact (Fig. 8B).

View larger version (27K):
[in this window]
[in a new window]
|
Figure 8.
Absence of synaptophysin-synaptobrevin complex in
PC 12 cells. A, Triton X-100 extracts of PC 12 cells
were immunoprecipitated using monoclonal antibodies against
synaptobrevin (syb) and synaptophysin
(syp). Immunoprecipitates (IP) and their
corresponding supernatants (S) were analyzed
using antibodies against synaptophysin and synaptobrevin.
B, PC 12 cell extracts and crude synaptic vesicle
extracts were incubated with full-length synaptobrevin (1-116). The
bead pellets and the corresponding supernatants were analyzed using
antibodies against synaptophysin, SNAP 25, and syntaxin.
|
|
We next investigated whether synaptosomal cytosol prepared from adult
brain induces formation of the synaptophysin-synaptobrevin complex in
synaptic vesicles from embryonic brain. Cytosolic fractions from
embryonic and adult synaptosomes (LS2) were prepared by
ultracentrifugation. When synaptic vesicles prepared from embryonic
brain were incubated with adult synaptosomal cytosol, binding between
synaptophysin and synaptobrevin was induced. No binding was observed
when the vesicles were incubated with cytosol prepared from embryonic
brain synaptosomes (Fig. 9A,
left lanes). Incubation with an embryonic synaptosomal
cytosolic preparation did not affect the synaptophysin-synaptobrevin complex of adult vesicles (Fig. 9A, right lanes),
nor was binding observed when the embryonic vesicles were incubated
with buffer instead of with embryonic synaptosomal cytosol (Fig.
9B). Note that the synaptosomal cytosol was completely free
of both synaptophysin and synaptobrevin (Fig. 9B).
Trypsin-digested adult synaptosomal cytosol was no longer able to
induce synaptophysin-synaptobrevin complex formation on embryonic
vesicles (Fig. 9C), strongly suggesting that the active
factor of the adult synaptosomal cytosol is a protein. We conclude that
the ability of synaptophysin to bind to synaptobrevin is regulated by a
posttranslational modification that is mediated by a cytosolic protein.
This protein is absent or inactive in embryonic brain but is
upregulated during synaptogenesis.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 9.
Induction of the synaptophysin-synaptobrevin
complex in embryonic synaptic vesicles by adult cytosol.
A, Crude synaptic vesicle fractions from embryonic day
20 or adult brain were incubated with synaptosomal cytosol fractions
(LS2, synaptosomal cytosol) obtained from either
adult (left lanes) or embryonic (ED 20,
right lanes) brain for 90 min at 37°C before they were
subjected to extraction and immunoprecipitation procedures using the
anti-synaptobrevin antibody. Immunoprecipitates (IP) and
their corresponding supernatants (S) were
analyzed using anti-synaptophysin or anti-synaptobrevin antibody.
B, Crude synaptic vesicle fractions from embryonic day
21 brain were incubated with either PBS or LS2 (synaptosomal
cytosol) obtained from adult brains and processed as
described in A. Note that the embryonic cytosol is
completely free of both synaptophysin and synaptobrevin (right
lanes). C, Crude synaptic vesicle fractions from
embryonic day 20 were incubated with either PBS or with undigested or
trypsin-digested LS2 (synaptosomal cytosol)
obtained from adult brains. Samples were extracted, immunoprecipitated,
and analyzed as described in A.
|
|
 |
DISCUSSION |
In the present study, we have shown that
synaptophysin-synaptobrevin complexes are upregulated during
development. Before synaptogenesis, the proteins do not interact,
despite the fact that they reside on the same vesicle population. Using
recombinant synaptobrevin as an exogenous binding partner, we have
shown further that the lack of interaction is caused by an unknown
modification of synaptophysin. Finally, we provide evidence that the
interaction can be induced by a cytosolic protein that is expressed or
active only in adult brain.
Several lines of evidence document that in immature neurons
synaptobrevin is fully functional with respect to exocytotic membrane fusion. First, the ability of synaptobrevin to form SNARE complexes does not change during development. Fully assembled SNARE complexes can
be precipitated from immature neurons as soon as the SNARE proteins are
expressed. Second, it has been demonstrated previously that
hypothalamic and cerebellar neurons grown for 3 d in culture are
able to secrete GABA by activity-dependent and tetanus toxin-sensitive exocytosis (Ahnert-Hilger et al., 1996 ; Kraszewski et al., 1996 ). Thus,
synaptobrevin-dependent exocytosis of synaptic vesicles or their
precursors can be observed long before mature synapses form. Third, in
the neuroendocrine cell line PC 12, which undergoes regulated and
synaptobrevin-dependent exocytosis, synaptophysin is unable to complex
with synaptobrevin. It should be kept in mind, however, that elongation
of neurites appears to be independent of synaptobrevin (Sweeney et al.,
1995 ; Ahnert-Hilger et al., 1996 ), although it is mediated by
exocytotic incorporation of precursor vesicles (Fletcher et al., 1991 ,
1994 ). In contrast, deletion of SNAP 25 (Osen-Sand et al., 1993 ) or
syntaxin (Igarashi et al., 1996 ) by neurotoxin cleavage impairs axonal
differentiation. Thus, it is possible that the exocytotic events
underlying membrane growth during differentiation and those underlying
regulated release of neurotransmitters are separately regulated.
If the ability of synaptophysin to complex with synaptobrevin is not an
essential prerequisite for synaptobrevin-dependent exocytosis, what
then could be the role of this interaction? Although other explanations
cannot be excluded at present, we believe that synaptophysin may
fine-tune synaptic responses by regulating the availability of
synaptobrevin to the SNARE complex in a positive manner. According to
this view, the main role of complex formation is to provide a rapidly
available pool of vesicular synaptobrevin for exocytotic membrane
fusion. Synaptophysin prevents the association of synaptobrevin with
vesicle-associated syntaxin and SNAP 25, which are known to reside in
significant quantities on synaptic vesicles (Walch-Solimena et al.,
1995 ) and to form complexes with synaptobrevin (Otto et al., 1997 ).
Such vesicular SNARE complexes probably represent a "dead-end"
status because synaptobrevin would require another round of ATP- and
NSF-driven disassembly to reacquire functionality in exocytosis. In
fact, the relative instability of the synaptophysin-synaptobrevin
complex may ensure that its formation is readily reversible when
synaptobrevin is needed to enter the SNARE complex during regulated
exocytosis. In this way, synaptophysin would recruit synaptobrevin
after disassembly of the SNARE complex after vesicle endocytosis by
keeping the extremely reactive synaptobrevin (Fasshauer et al., 1997 )
from entering the SNARE complex in an uncontrolled manner and releasing
it when it is required for another round of rapid exocytosis. Support for such a role is also provided by the observation that overexpression of synaptophysin enhances neurotransmitter release (Alder et al., 1995 ).
The molecular mechanism underlying the synaptophysin-synaptobrevin
interaction remains to be established. The presence of both proteins on
the same vesicles in embryonic brain excludes a differential sorting
during development, a process that has been suggested previously for PC
12 cells (Bauerfeind and Huttner, 1993 ). Homodimerization of
synaptobrevin (Laage and Langosch, 1997 ), which is observed primarily
in adult brain (Fig. 2), appears not to play a role in the
synaptophysin-synaptobrevin interaction seeing that cross-linking data
seem to suggest a complex of synaptophysin with one rather than two
synaptobrevins. Further experiments are necessary, however, to
determine the exact stoichiometry of the synaptophysin-synaptobrevin
complex. Our data strongly suggest that the binding is regulated by a
direct posttranslational modification of synaptophysin, but its nature
is still unknown. According to our preliminary data, protein
phosphorylation of synaptophysin appears not to be involved. Similarly,
regulation is apparently not mediated by a rearrangement of disulfide
bonds in synaptophysin. When the disulfide bonds are reduced by
SH-agents, the synaptophysin-synaptobrevin complex falls apart but
readily reassembles once the sulfhydril reagents are removed. However,
such treatment fails to induce synaptobrevin-binding in embryonic
synaptophysin (our unpublished observations). The cytosolic
protein capable of inducing formation of the
synaptophysin-synaptobrevin complex is currently under investigation.
Mice that do not express synaptophysin nevertheless exhibit functional
neurotransmission, indicating that synaptophysin is not an absolute
requirement for neurotransmitter release as such (Eshkind and Leube,
1995 ; McMahon et al., 1996 ), although synaptophysin isoforms, such as
synaptoporin, may substitute at least partially for synaptophysin in
these mice. So far, the data on members of the synaptophysin family
(Janz and Südhof, 1998 ) suggest that synaptophysin and its
analogs may be involved in fine-tuning of neurotransmitter release in
adult neurons and probably in sorting and vesicle biogenesis in
developing neurons. Our findings reported here provide a clue as to how
such fine control may be achieved. The developmental profile of the
synaptophysin-synaptobrevin interaction, leading from a less
controlled to a highly regulated synaptobrevin, may enable synaptic
vesicles to adjust to the high efficiency of exocytosis in
differentiated synapses.
 |
FOOTNOTES |
Received Sept. 10, 1998; revised Dec. 11, 1998; accepted Dec. 22, 1998.
This work was supported by Deutsche Forschungsgemeinschaft Grant SFB
515. We thank Evelyn Heuckendorf for expert technical assistance.
Correspondence should be addressed to Dr. Gudrun Ahnert-Hilger,
Institut für Anatomie der Charité,
Humboldt-Universität zu Berlin, Philippstra e 12, 10115 Berlin, Germany.
 |
REFERENCES |
-
Ahnert-Hilger G,
Kutay U,
Chahoud I,
Rapoport TA,
Wiedenmann B
(1996)
Synaptobrevin is essential for secretion but not for the development of synaptic processes.
Eur J Cell Biol
70:1-11[Web of Science][Medline].
-
Alder J,
Kanki H,
Valtorta F,
Greengard P,
Poo MM
(1995)
Overexpression of synaptophysin enhances neurotransmitter secretion at Xenopus neuromuscular synapses.
J Neurosci
15:511-519[Abstract].
-
Barnstable CJ,
Hofstein R,
Akagawa K
(1985)
A marker of early amacrine cell development in rat retina.
Brain Res
352:286-290[Medline].
-
Bauerfeind R, Huttner WB (1993) Biogenesis of constitutive
secretory vesicles, secretory granules and synaptic vesicles. Curr Opin
Cell Biol [Erratum 5:1106] 5:628-635.
-
Baumert M,
Maycox PR,
Navone F,
DeCamilli P,
Jahn R
(1989)
Synaptobrevin: an integral membrane protein of 18,000 daltons in small synaptic vesicles.
EMBO J
8:379-384[Web of Science][Medline].
-
Betz A,
Okamoto M,
Benseler F,
Brose N
(1997)
Direct interaction of the rat unc-13 homologue munc-13-1 with the N terminus of syntaxin.
J Biol Chem
272:2520-2526[Abstract/Free Full Text].
-
Brose N,
Petrenko AG,
Südhof TC,
Jahn R
(1992)
Synaptotagmin: a calcium sensor on synaptic vesicle surface.
Science
256:1021-1025[Abstract/Free Full Text].
-
Burger PM,
Mehl E,
Maycox PR,
Baumert M,
Lottspeich F,
DeCamilli P,
Jahn R
(1989)
Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate.
Neuron
3:715-720[Web of Science][Medline].
-
Calakos N,
Scheller RH
(1994)
Vesicle-associated membrane protein and synaptophysin are associated on the synaptic vesicle.
J Biol Chem
269:24534-24537[Abstract/Free Full Text].
-
Chapman ER,
An S,
Barton N,
Jahn R
(1994)
SNAP-25, a t-SNARE which binds both syntaxin and synaptobrevin via domains that may form coiled coils.
J Biol Chem
269:27427-27432[Abstract/Free Full Text].
-
Edelmann L,
Hanson PI,
Chapman ER,
Jahn R
(1995)
Synaptobrevin binding to synaptophysin: a potential mechanism for controlling exocytotic fusion machine.
EMBO J
14:224-231[Web of Science][Medline].
-
Eshkind LG,
Leube RE
(1995)
Mice lacking synaptophysin reproduce and form typical synaptic vesicles.
Cell Tissue Res
282:423-433[Web of Science][Medline].
-
Fasshauer D,
Otto H,
Eliason WK,
Jahn R,
Brünger AT
(1997)
Structural changes are associated with the soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor complex formation.
J Biol Chem
272:28036-28041[Abstract/Free Full Text].
-
Fletcher TL,
Cameron P,
DeCamilli P,
Banker G
(1991)
The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture.
J Neurosci
11:1617-1626[Abstract].
-
Fletcher TL,
DeCamilli P,
Banker G
(1994)
Synaptogenesis in hippocampal cultures: evidence indicating that axons and dendrites become competent to form synapses at different stages of neuronal development.
J Neurosci
14:6695-6706[Abstract].
-
Hanson PI,
Roth R,
Morosaki H,
Jahn R,
Heuser JE
(1997a)
Structure and conformational changes in NSF and ist membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy.
Cell
90:523-535[Web of Science][Medline].
-
Hanson PI,
Heuser JE,
Jahn R
(1997b)
Neurotransmitter release
four years of SNARE complexes.
Curr Opin Neurobiol
7:310-315[Web of Science][Medline]. -
Hata Y,
Slaughter GH,
Südhof TC
(1993)
Synaptic vesicle fusion complex contains unc-18 homologue bound to syntaxin.
Nature
366:347-351[Medline].
-
Huttner WB,
Schiebler W,
Greengard P,
DeCamilli P
(1983)
Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation.
J Cell Biol
96:1374-1388[Abstract/Free Full Text].
-
Igarashi M,
Kozaki S,
Terakawa S,
Kawano S,
Ide C,
Komiya Y
(1996)
Growth-cone collapse and inhibition of neurite growth induced by botulinum neurotoxin C1: a t-SNARE is involved in axonal growth.
J Cell Biol
134:205-215[Abstract/Free Full Text].
-
Jahn R,
Hanson PI
(1998)
Membrane fusion. SNAREs line up in new environment.
Nature
393:14-15[Medline].
-
Janz R,
Südhof TC
(1998)
Cellugyrin, a novel ubiquitous form of synaptogyrin that is phosphorylated by pp60c-src.
J Biol Chem
273:2851-2857[Abstract/Free Full Text].
-
Jahn R,
Schiebler W,
Oimet C,
Greengard P
(1985)
A 38,000 dalton membrane protein (p38) present in synaptic vesicles.
Proc Natl Acad Sci USA
82:4137-4141[Abstract/Free Full Text].
-
Johnston PA,
Südhof TC
(1990)
The multisubunit structure of synaptophysin. Relationship between disulfide bonding and homo-oligomerization.
J Biol Chem
265:8869-8873[Abstract/Free Full Text].
-
Kraszewski K,
Daniell L,
Mundigl O,
DeCamilli P
(1996)
Mobility of synaptic vesicles in nerve endings monitored by recovery from photobleaching of synaptic vesicle-associated fluorescence.
J Neurosci
16:5905-5913[Abstract/Free Full Text].
-
Kutay U,
Ahnert-Hilger G,
Hartmann E,
Wiedenmann B,
Rapoport TA
(1995)
Transport route for synaptobrevin via a novel pathway of insertion into the endoplasmic reticulum membrane.
EMBO J
14:217-223[Web of Science][Medline].
-
Laage R,
Langosch D
(1997)
Dimerization of the synaptic vesicle protein synaptobrevin (vesicle-associated membrane protein) II depends on specific residues within the transmembrane domain.
Eur J Biochem
249:540-546[Web of Science][Medline].
-
Matteoli M,
Viderio C,
Kraszewski K,
Mundigl O,
Coco S,
Fumagalli G,
DeCamilli P
(1995)
Mechanisms of synaptogenesis in hippocampal neurons in primary culture.
J Physiol (Paris)
89:51-55[Web of Science][Medline].
-
McMahon HT,
Boshakov VY,
Janz R,
Hammer RE,
Siegelbaum SA,
Südhof TC
(1996)
Synaptophysin, a major vesicle protein, is not es-sential for neurotransmitter release.
Proc Natl Acad Sci USA
93:4760-4764[Abstract/Free Full Text].
-
Okamoto M,
Südhof TC
(1997)
Munc-18 interacting proteins in synaptic vesicle exocytosis.
J Biol Chem
272:31459-31464[Abstract/Free Full Text].
-
Osen-Sand A,
Catsicas M,
Staple JK,
Jones KA,
Ayala G,
Knowles J,
Grenningloh G,
Catsicas S
(1993)
Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo.
Nature
364:445-448[Medline].
-
Otto H,
Hanson PI,
Jahn R
(1997)
Assembly and disassembly of ternary complex of synaptobrevin, syntaxin and SNAP-25 in the membrane of synaptic vesicles.
Proc Natl Acad Sci USA
94:6197-6201[Abstract/Free Full Text].
-
Söllner T,
Whiteheart SW,
Brunner M,
Erdjument-Bromage H,
Geromanos S,
Tempst T,
Rothman JE
(1993)
SNAP receptors implicated in vesicle targeting and fusion.
Nature
362:318-324[Medline].
-
Sutton B,
Fasshauer D,
Jahn R,
Brünger AT
(1998)
Crystal structure of a core synaptic fusion complex at 2.4 A resolution.
Nature
395:347-353[Medline].
-
Sweeney ST,
Broadie K,
Keane J,
Niemann H,
O'Kane CJ
(1995)
Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioural defects.
Neuron
14:341-351[Web of Science][Medline].
-
Veh RW,
Lichtinghagen R,
Sewing S,
Wunder F,
Grumbach IM,
Pongs O
(1995)
Immunocytochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain.
Eur J Biochem
7:2189-2205.
-
Walch-Solimena C,
Blasi J,
Edelmann L,
Chapman ER,
Fischer von Mollard G,
Jahn R
(1995)
The t-SNAREs syntaxin and SNAP-25 are present on organelles that participate in synaptic vesicle recycling.
J Cell Biol
128:637-645[Abstract/Free Full Text].
Copyright © 1999 Society for Neuroscience 0270-6474/99/1961922-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Darna, I. Schmutz, K. Richter, S. V. Yelamanchili, G. Pendyala, M. Holtje, U. Albrecht, and G. Ahnert-Hilger
Time of Day-dependent Sorting of the Vesicular Glutamate Transporter to the Plasma Membrane
J. Biol. Chem.,
February 13, 2009;
284(7):
4300 - 4307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Brunk, C. Blex, D. Speidel, N. Brose, and G. Ahnert-Hilger
Ca2+-dependent Activator Proteins of Secretion Promote Vesicular Monoamine Uptake
J. Biol. Chem.,
January 9, 2009;
284(2):
1050 - 1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Brunk, C. Blex, C. Sanchis-Segura, J. Sternberg, S. Perreau-Lenz, A. Bilbao, H. Hortnagl, J. Baron, J. Juranek, G. Laube, et al.
Deletion of Go2{alpha} abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system
FASEB J,
October 1, 2008;
22(10):
3736 - 3746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Frigo and D. P. McDonnell
Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation
Mol. Cancer Ther.,
March 1, 2008;
7(3):
659 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Vahl, M. Tauchi, T. S. Durler, E. E. Elfers, T. M. Fernandes, R. D. Bitner, K. S. Ellis, S. C. Woods, R. J. Seeley, J. P. Herman, et al.
Glucagon-Like Peptide-1 (GLP-1) Receptors Expressed on Nerve Terminals in the Portal Vein Mediate the Effects of Endogenous GLP-1 on Glucose Tolerance in Rats
Endocrinology,
October 1, 2007;
148(10):
4965 - 4973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Yelamanchili, G. Pendyala, I. Brunk, M. Darna, U. Albrecht, and G. Ahnert-Hilger
Differential Sorting of the Vesicular Glutamate Transporter 1 into a Defined Vesicular Pool Is Regulated by Light Signaling Involving the Clock Gene Period2
J. Biol. Chem.,
June 9, 2006;
281(23):
15671 - 15679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Abraham, H. Hutter, M. T. Palfreyman, G. Spatkowski, R. M. Weimer, R. Windoffer, E. M. Jorgensen, and R. E. Leube
Synaptic tetraspan vesicle membrane proteins are conserved but not needed for synaptogenesis and neuronal function in Caenorhabditis elegans
PNAS,
May 23, 2006;
103(21):
8227 - 8232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Winter, I. Brunk, D. J. Walther, M. Holtje, M. Jiang, J.-U. Peter, S. Takamori, R. Jahn, L. Birnbaumer, and G. Ahnert-Hilger
G{alpha}o2 Regulates Vesicular Glutamate Transporter Activity by Changing Its Chloride Dependence
J. Neurosci.,
May 4, 2005;
25(18):
4672 - 4680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Sandberg and P. Low
Altered Interaction and Expression of Proteins Involved in Neurosecretion in Scrapie-infected GT1-1 Cells
J. Biol. Chem.,
January 14, 2005;
280(2):
1264 - 1271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hewitt, R. Barrie, M. Graham, K. Bogus, J. C. Leiter, and J. S. Erlichman
Ventilatory effects of gap junction blockade in the RTN in awake rats
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2004;
287(6):
R1407 - R1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bacci, S. Coco, E. Pravettoni, U. Schenk, S. Armano, C. Frassoni, C. Verderio, P. De Camilli, and M. Matteoli
Chronic Blockade of Glutamate Receptors Enhances Presynaptic Release and Downregulates the Interaction between Synaptophysin-Synaptobrevin-Vesicle-Associated Membrane Protein 2
J. Neurosci.,
September 1, 2001;
21(17):
6588 - 6596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao and M. L. Nonet
A Conserved Mechanism of Synaptogyrin Localization
Mol. Biol. Cell,
August 1, 2001;
12(8):
2275 - 2289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Lee, Y. L. Zhu, Z. Sun, H. Rhee, A. Jeromin, J. Roder, and P. S. Dannies
Accumulation of Synaptosomal-Associated Protein of 25 kDa (SNAP-25) and Other Proteins Associated with the Secretory Pathway in GH4C1 Cells Upon Treatment with Estradiol, Insulin, and Epidermal Growth Factor
Endocrinology,
September 1, 2000;
141(9):
3485 - 3492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Grosse, A. Draguhn, L. Hohne, R. Tapp, R. W. Veh, and G. Ahnert-Hilger
Expression of Kv1 Potassium Channels in Mouse Hippocampal Primary Cultures: Development and Activity-Dependent Regulation
J. Neurosci.,
March 1, 2000;
20(5):
1869 - 1882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tartaglia, J. Du, W. J. Tyler, E. Neale, L. Pozzo-Miller, and B. Lu
Protein Synthesis-dependent and -independent Regulation of Hippocampal Synapses by Brain-derived Neurotrophic Factor
J. Biol. Chem.,
September 28, 2001;
276(40):
37585 - 37593.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|